Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Mar 08, 2024 | Sale | $26.67 | 27,199 | 725,344 | 159,383 | Mar 13, 2024, 06:04 AM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Mar 11, 2024 | Sale | $25.70 | 2,292 | 58,904 | 156,800 | Mar 13, 2024, 06:04 AM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Mar 08, 2024 | Sale | $15.89 | 180,000 | 2,860,131 | 231,184 | Mar 13, 2024, 06:04 AM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Mar 11, 2024 | Sale | $15.99 | 37,426 | 598,592 | 159,009 | Mar 13, 2024, 06:04 AM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Mar 11, 2024 | Sale | $25.70 | 1,585 | 40,735 | 151,590 | Mar 12, 2024, 09:58 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Mar 12, 2024 | Sale | $25.58 | 1,030 | 26,347 | 150,560 | Mar 12, 2024, 09:58 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 08, 2024 | Sale | $15.88 | 172,504 | 2,739,301 | 208,207 | Mar 12, 2024, 09:57 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 11, 2024 | Sale | $25.28 | 2,672 | 67,542 | 120,873 | Mar 12, 2024, 09:57 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | Mar 08, 2024 | Sale | $15.74 | 726,686 | 11,434,554 | 917,728 | Mar 12, 2024, 09:56 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | Mar 11, 2024 | Sale | $17.02 | 116,387 | 1,981,142 | 604,385 | Mar 12, 2024, 09:56 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Mar 11, 2024 | Sale | $25.70 | 2,081 | 53,482 | 152,352 | Mar 12, 2024, 09:42 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | Mar 07, 2024 | Sale | $25.85 | 9,086 | 234,873 | 554,385 | Mar 11, 2024, 09:57 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Mar 07, 2024 | Sale | $25.85 | 2,373 | 61,342 | 154,433 | Mar 11, 2024, 09:56 PM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Mar 07, 2024 | Sale | $25.85 | 1,591 | 41,127 | 186,291 | Mar 11, 2024, 09:56 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Mar 07, 2024 | Sale | $25.86 | 9,921 | 256,585 | 154,732 | Mar 11, 2024, 09:52 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Mar 07, 2024 | Sale | $25.85 | 2,434 | 62,919 | 141,184 | Mar 11, 2024, 09:50 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 07, 2024 | Sale | $25.85 | 2,273 | 58,757 | 121,955 | Mar 11, 2024, 09:45 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Mar 01, 2024 | Sale | $30.05 | 46,534 | 1,398,347 | 1,458,691 | Mar 05, 2024, 05:08 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LP | 10% Owner | Mar 01, 2024 | Sale | $30.05 | 29,435 | 884,522 | 1,458,691 | Mar 05, 2024, 05:07 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LP | 10% Owner | Mar 01, 2024 | Sale | $30.05 | 17,099 | 513,825 | 847,388 | Mar 05, 2024, 05:07 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | Feb 29, 2024 | Option Exercise | $16.52 | 11,040 | 182,381 | 568,991 | Mar 01, 2024, 09:38 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | Mar 01, 2024 | Sale | $17.29 | 188,960 | 3,267,138 | 657,951 | Mar 01, 2024, 09:38 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Feb 29, 2024 | Option Exercise | $14.12 | 8,536 | 120,486 | 147,886 | Mar 01, 2024, 09:37 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Mar 01, 2024 | Sale | $14.68 | 48,520 | 712,205 | 167,878 | Mar 01, 2024, 09:37 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | Feb 29, 2024 | Option Exercise | $14.26 | 6,858 | 97,829 | 127,657 | Mar 01, 2024, 09:37 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | Mar 01, 2024 | Sale | $14.64 | 18,622 | 272,589 | 133,539 | Mar 01, 2024, 09:37 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 26, 2024 | Sale | $23.72 | 248,219 | 5,886,673 | 6,216,250 | Feb 28, 2024, 07:15 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 27, 2024 | Sale | $24.41 | 368,699 | 8,998,426 | 5,878,544 | Feb 28, 2024, 07:15 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 28, 2024 | Sale | $24.84 | 190,920 | 4,741,804 | 5,700,521 | Feb 28, 2024, 07:15 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LP | 10% Owner | Feb 28, 2024 | Sale | $24.84 | 36,246 | 900,228 | 1,488,486 | Feb 28, 2024, 07:13 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates XI, LLC | 10% Owner | Feb 26, 2024 | Sale | $23.72 | 201,095 | 4,769,096 | 6,216,250 | Feb 28, 2024, 07:13 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates XI, LLC | 10% Owner | Feb 26, 2024 | Sale | $23.72 | 47,124 | 1,117,577 | 1,564,932 | Feb 28, 2024, 07:13 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LP | 10% Owner | Feb 27, 2024 | Sale | $24.41 | 298,702 | 7,290,088 | 5,878,544 | Feb 28, 2024, 07:13 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates XI, LLC | 10% Owner | Feb 27, 2024 | Sale | $24.41 | 69,997 | 1,708,338 | 1,514,874 | Feb 28, 2024, 07:13 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LLC | 10% Owner | Feb 28, 2024 | Sale | $24.84 | 154,674 | 3,841,576 | 5,700,521 | Feb 28, 2024, 07:13 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Feb 28, 2024 | Sale | $25.00 | 407 | 10,175 | 163,096 | Feb 28, 2024, 05:06 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 22, 2024 | Sale | $22.66 | 119,360 | 2,704,698 | 6,512,104 | Feb 23, 2024, 06:59 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 23, 2024 | Sale | $22.70 | 196,928 | 4,470,266 | 6,352,562 | Feb 23, 2024, 06:59 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 21, 2024 | Sale | $22.57 | 184,501 | 4,164,817 | 6,666,628 | Feb 23, 2024, 06:59 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Opportunity Fund I, L.P. | 10% Owner | Feb 21, 2024 | Sale | $22.57 | 184,501 | 4,164,817 | 6,666,628 | Feb 23, 2024, 06:58 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates XI, LLC | 10% Owner | Feb 22, 2024 | Sale | $22.66 | 119,360 | 2,704,698 | 6,512,104 | Feb 23, 2024, 06:58 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates Opportunity II, LLC | 10% Owner | Feb 23, 2024 | Sale | $22.70 | 159,542 | 3,621,604 | 6,352,562 | Feb 23, 2024, 06:58 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Opportunity Fund I, L.P. | 10% Owner | Feb 23, 2024 | Sale | $22.70 | 37,386 | 848,662 | 1,585,137 | Feb 23, 2024, 06:58 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 15, 2024 | Sale | $23.89 | 177,906 | 4,249,600 | 7,150,324 | Feb 20, 2024, 06:36 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 16, 2024 | Sale | $23.14 | 162,707 | 3,765,040 | 6,985,504 | Feb 20, 2024, 06:36 PM | |
DYN | Dyne Therapeutics, Inc. | Rhodes Jason P | Director | Feb 20, 2024 | Sale | $22.72 | 169,539 | 3,852,652 | 6,819,475 | Feb 20, 2024, 06:36 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates XI, LLC | 10% Owner | Feb 20, 2024 | Sale | $22.72 | 169,539 | 3,852,652 | 6,819,475 | Feb 20, 2024, 06:35 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Fund XI, L.P. | 10% Owner | Feb 15, 2024 | Sale | $23.89 | 177,906 | 4,249,600 | 7,150,324 | Feb 20, 2024, 06:35 PM | |
DYN | Dyne Therapeutics, Inc. | Atlas Venture Associates XI, LLC | 10% Owner | Feb 16, 2024 | Sale | $23.14 | 162,707 | 3,765,040 | 6,985,504 | Feb 20, 2024, 06:35 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Feb 12, 2024 | Sale | $25.07 | 5,493 | 137,710 | 163,503 | Feb 14, 2024, 04:27 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Jan 26, 2024 | Sale | $25.00 | 100 | 2,500 | 168,996 | Jan 26, 2024, 07:49 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Jan 26, 2024 | Sale | $12.63 | 40,000 | 505,110 | 163,618 | Jan 26, 2024, 07:48 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | Jan 26, 2024 | Sale | $12.69 | 26,000 | 329,810 | 137,228 | Jan 26, 2024, 07:47 PM | |
DYN | Dyne Therapeutics, Inc. | Kersten Dirk | Director | Jan 09, 2024 | Buy | $17.50 | 1,714,285 | 29,999,988 | 6,416,793 | Jan 11, 2024, 04:31 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | Jan 03, 2024 | Sale | $10.16 | 102,366 | 1,039,676 | 636,154 | Jan 04, 2024, 09:49 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | CEO & President | Jan 04, 2024 | Sale | $11.84 | 437,072 | 5,173,050 | 803,507 | Jan 04, 2024, 09:49 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Jan 04, 2024 | Option Exercise | $12.18 | 65,127 | 793,027 | 199,259 | Jan 04, 2024, 09:48 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Jan 03, 2024 | Sale | $10.01 | 90,652 | 906,998 | 221,911 | Jan 04, 2024, 09:48 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Jan 02, 2024 | Sale | $13.10 | 11,900 | 155,890 | 143,618 | Jan 04, 2024, 09:47 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Jan 03, 2024 | Sale | $9.73 | 35,982 | 350,195 | 161,609 | Jan 04, 2024, 09:47 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Jan 04, 2024 | Option Exercise | $9.39 | 4,018 | 37,709 | 145,627 | Jan 04, 2024, 09:47 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | SVP, Head of Finance & Admin. | Jan 03, 2024 | Sale | $9.92 | 26,000 | 257,920 | 137,228 | Jan 04, 2024, 09:46 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Dec 14, 2023 | Sale | $12.02 | 2,376 | 28,560 | 124,228 | Dec 14, 2023, 04:59 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Dec 11, 2023 | Sale | $10.72 | 1,380 | 14,794 | 126,604 | Dec 12, 2023, 05:35 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Dec 11, 2023 | Sale | $10.72 | 1,245 | 13,346 | 155,518 | Dec 12, 2023, 05:34 PM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Dec 11, 2023 | Sale | $10.72 | 1,616 | 17,324 | 187,882 | Dec 12, 2023, 05:34 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Dec 12, 2023 | Sale | $10.55 | 978 | 10,318 | 169,096 | Dec 12, 2023, 05:33 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Dec 11, 2023 | Sale | $10.72 | 1,688 | 18,095 | 170,074 | Dec 12, 2023, 05:33 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | Dec 11, 2023 | Sale | $10.72 | 7,585 | 81,311 | 584,971 | Dec 12, 2023, 05:33 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Dec 11, 2023 | Sale | $10.72 | 1,467 | 15,726 | 176,585 | Dec 12, 2023, 05:32 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Dec 04, 2023 | Sale | $12.01 | 681 | 8,179 | 129,856 | Dec 06, 2023, 06:13 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Dec 06, 2023 | Sale | $12.01 | 1,872 | 22,483 | 127,984 | Dec 06, 2023, 06:13 PM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Nov 02, 2023 | Sale | $7.40 | 9,939 | 73,549 | 94,605 | Nov 02, 2023, 05:16 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Sep 18, 2023 | Sale | $9.41 | 1,290 | 12,139 | 40,795 | Sep 20, 2023, 04:49 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Sep 18, 2023 | Sale | $9.41 | 1,261 | 11,866 | 60,605 | Sep 20, 2023, 04:49 PM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Sep 18, 2023 | Sale | $9.41 | 2,672 | 25,144 | 104,544 | Sep 20, 2023, 04:48 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | Sep 18, 2023 | Sale | $9.41 | 12,032 | 113,221 | 233,679 | Sep 20, 2023, 04:47 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Sep 18, 2023 | Sale | $9.41 | 1,436 | 13,513 | 84,334 | Sep 20, 2023, 04:47 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Sep 12, 2023 | Sale | $10.41 | 1,707 | 17,770 | 89,250 | Sep 13, 2023, 07:56 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Sep 12, 2023 | Sale | $10.41 | 1,397 | 14,543 | 42,085 | Sep 13, 2023, 07:53 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | Chief Business Officer | Sep 12, 2023 | Sale | $10.41 | 1,266 | 13,179 | 61,866 | Sep 13, 2023, 07:53 PM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Sep 12, 2023 | Sale | $10.41 | 1,635 | 17,020 | 107,216 | Sep 13, 2023, 07:51 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | Sep 12, 2023 | Sale | $10.41 | 7,672 | 79,866 | 245,711 | Sep 13, 2023, 07:50 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Sep 12, 2023 | Sale | $10.41 | 1,484 | 15,448 | 85,770 | Sep 13, 2023, 07:50 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Jun 13, 2023 | Sale | $7.05 | 81,390 | 574,078 | 93,482 | Jun 15, 2023, 05:46 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Jun 15, 2023 | Sale | $12.03 | 10,000 | 120,300 | 43,482 | Jun 15, 2023, 05:46 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | Jun 12, 2023 | Sale | $13.00 | 1,000 | 13,000 | 64,391 | Jun 14, 2023, 06:40 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | Jun 13, 2023 | Sale | $12.43 | 1,259 | 15,649 | 63,132 | Jun 14, 2023, 06:40 PM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Jun 13, 2023 | Sale | $12.43 | 1,625 | 20,199 | 108,851 | Jun 14, 2023, 06:40 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Jun 13, 2023 | Sale | $12.43 | 1,698 | 21,106 | 90,957 | Jun 14, 2023, 06:40 PM | |
DYN | Dyne Therapeutics, Inc. | Beskrovnaya Oxana | Chief Scientific Officer | Jun 13, 2023 | Sale | $12.43 | 1,475 | 18,334 | 87,254 | Jun 14, 2023, 06:39 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | Jun 08, 2023 | Sale | $9.20 | 91,088 | 837,681 | 330,771 | Jun 12, 2023, 09:22 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | Jun 09, 2023 | Option Exercise | $7.19 | 153,164 | 1,100,483 | 346,353 | Jun 12, 2023, 09:22 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | Jun 12, 2023 | Option Exercise | $7.08 | 359,108 | 2,544,003 | 441,131 | Jun 12, 2023, 09:22 PM | |
DYN | Dyne Therapeutics, Inc. | Scalzo Richard William | See Remarks | Mar 14, 2023 | Sale | $13.33 | 1,311 | 17,476 | 54,872 | Mar 15, 2023, 05:51 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | Mar 13, 2023 | Sale | $13.00 | 1,000 | 13,000 | 66,600 | Mar 15, 2023, 05:50 PM | |
DYN | Dyne Therapeutics, Inc. | McNeill Jonathan | See Remarks | Mar 14, 2023 | Sale | $13.33 | 1,209 | 16,116 | 65,391 | Mar 15, 2023, 05:50 PM | |
DYN | Dyne Therapeutics, Inc. | HIGH SUSANNA GATTI | Chief Operating Officer | Mar 14, 2023 | Sale | $13.33 | 1,559 | 20,781 | 110,476 | Mar 15, 2023, 05:50 PM | |
DYN | Dyne Therapeutics, Inc. | Farwell Wildon | Chief Medical Officer | Mar 14, 2023 | Sale | $13.33 | 7,441 | 99,189 | 92,655 | Mar 15, 2023, 05:49 PM | |
DYN | Dyne Therapeutics, Inc. | Brumm Joshua T | See Remarks | Mar 14, 2023 | Sale | $13.33 | 7,318 | 97,549 | 322,483 | Mar 15, 2023, 05:49 PM |